Atlas Trials

A Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy Participants

Clinical trial NCT07662057 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07662057
Sponsor
Arcus Biosciences, Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2026-07-01
Primary completion
2026-12-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.